Docencia
HCV reinfection after HCV therapy among HIV/HCV coinfected individuals in Europe. Amele S and the EuroSIDA study group. HIV Medicine 2021;00:1–9 (18/03/2022).
Dr. Carlos Dueñas Gutiérrez
Hospital Clínico Universitario de Valladolid.
Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study (18/02/2022)
Dra. Rocío Montejano
Hospital Universitario La Paz, Madrid
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study. (04/02/2022)
Dr. Juan Emilio Losa
Hospital Universitario Fundación Alcorcón, Madrid
Associations of Hepatosteatosis with cardiovascular disease in HIV-Positive and HIV-Negative patients: The Liverpool HIV-Heart Project (21/01/2022)
Dr. Sergio Reus Pujadas
Hospital General Universitario de Alicante.
Quality of life in people living with HIV in Romania and Spain (10/01/2022)
Dra. Inmaculada Jarrín
Centro Nacional de Epidemiología, Instituto de Salud Carlos III.
A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation (20/12/2021)
Dra. Beatriz Mothe Pujadas
IrsiCaixa, Servicio Enfermedades Infecciosas
Hospital Germans Trias i Pujol, Badalona.
Prevalence of Gastrointestinal Pathogens Detected by Multiplex Polymerase Chain Reaction in a Prospective Cohort of Men Who Have Sex With Men Taking Human Immunodeficiency Virus Preexposure Prophylaxis—New York City, 2019–2020 (10-12-2021)
Dr. Carlos Dueñas
Hospital Clínico Universitario de Valladolid.
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/microlitre (26-11-2021)
Dra. Rocio Montejano
Hospital Universitario La Paz, Madrid.
All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Vitus Viremia During COmbination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
Dr. Sergio Reus
Hospital General Universitario de Alicante.
Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
Dr. Juan Emilio Losa
Hospital Universitario Fundación Alcorcón, Madrid.
